首页>
外国专利>
Use of citral for treating focal segmental glomerulosclerosis
Use of citral for treating focal segmental glomerulosclerosis
展开▼
机译:柠檬醛治疗局灶性节段性肾小球硬化的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a new use of citral for manufacturing a medicament for treating focal segmental glomerulosclerosis (FSGS). Particularly, the present invention discloses that citral is effective in alleviating symptoms of FSGS, including reducing glomerular epithelial hyperplasia lesions (EPHLs), peri-glomerular inflammation or glomerular hyalinosis or sclerosis, and also reducing proteinuria or hematuria or lowering serum urea nitrogen level or serum creatinine level in the subject.
展开▼